Search

everythinglearnresearchcommunity

for

Search:↓

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Flightless I protein affects hair growth, with low levels delaying it and high levels increasing hair length in rodents.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Birth control pills can help reduce mild to moderate acne in women.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.